TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, cilt.14, sa.4, ss.199-202, 2017 (ESCI, Scopus, TRDizin)
Objective: The aim of this study was to compare the effect of corifollitropin alfa (CFA) and recombinant follicle-stimulating hormone (rFSH) in poor-responder patients undergoing antagonist cycles.